Dr Stephanie Sara Richard, MD - Medicare Pathology in Lake Charles, LA

Dr Stephanie Sara Richard, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Lake Charles, Louisiana. She went to Louisiana State University School Of Medicine In New Orleans and graduated in 2002 and has 22 years of diverse experience with area of expertise as Pathology. She is a member of the group practice The Pathology Laboratory, Inc. and her current practice location is 830 W Bayou Pines Dr, Lake Charles, Louisiana. You can reach out to her office (for appointments etc.) via phone at (337) 436-9557.

Dr Stephanie Sara Richard is licensed to practice in Louisiana (license number MD.026043) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1376582676.

Contact Information

Dr Stephanie Sara Richard, MD
830 W Bayou Pines Dr,
Lake Charles, LA 70601-7097
(337) 436-9557
(337) 312-1311



Physician's Profile

Full NameDr Stephanie Sara Richard
GenderFemale
SpecialityPathology
Experience22 Years
Location830 W Bayou Pines Dr, Lake Charles, Louisiana
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Stephanie Sara Richard attended and graduated from Louisiana State University School Of Medicine In New Orleans in 2002
  NPI Data:
  • NPI Number: 1376582676
  • Provider Enumeration Date: 06/05/2006
  • Last Update Date: 08/26/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0244242808
  • Enrollment ID: I20060622000267

Medical Identifiers

Medical identifiers for Dr Stephanie Sara Richard such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1376582676NPI-NPPES
209946701MedicaidTX
1056081MedicaidLA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology MD.026043 (Louisiana)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
The Pathology Laboratory, Inc.09412407825

News Archive

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

A patient's tolerance for risky decisions can predict chances of opioid relapse

People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

Survey reveals surgery residents concerned with motivations to pursue surgical careers

A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Stephanie Sara Richard allows following entities to bill medicare on her behalf.
Entity NamePathology Group Of Louisiana, A Professional Medical Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1093843450
PECOS PAC ID: 6507856317
Enrollment ID: O20040514000007

News Archive

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

A patient's tolerance for risky decisions can predict chances of opioid relapse

People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

Survey reveals surgery residents concerned with motivations to pursue surgical careers

A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

Read more Medical News

› Verified 5 days ago

Entity NameThe Pathology Laboratory, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215917588
PECOS PAC ID: 0941240782
Enrollment ID: O20050511000192

News Archive

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

A patient's tolerance for risky decisions can predict chances of opioid relapse

People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

Survey reveals surgery residents concerned with motivations to pursue surgical careers

A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephanie Sara Richard is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Stephanie Sara Richard, MD
830 W Bayou Pines Dr,
Lake Charles, LA 70601-7097

Ph: (337) 436-9557
Dr Stephanie Sara Richard, MD
830 W Bayou Pines Dr,
Lake Charles, LA 70601-7097

Ph: (337) 436-9557

News Archive

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

A patient's tolerance for risky decisions can predict chances of opioid relapse

People in treatment for opioid addiction are more likely to relapse when they become more tolerant of risks, according to a study by Rutgers and other institutions. The findings can help clinicians better predict which patients are most vulnerable.

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

Survey reveals surgery residents concerned with motivations to pursue surgical careers

A survey of nearly 4,500 general surgery residents finds that the majority are satisfied with their training and relationships with faculty and peers, but also indicated concerns regarding motivations for pursuing surgical careers and the need to complete specialty training, according to a study in the September 23/30 issue of JAMA, a theme issue on medical education.

Read more News

› Verified 5 days ago


Pathology Doctors in Lake Charles, LA

Dr. Robert L Rumsey, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601
Phone: 337-436-9557    Fax: 337-312-1311
Dr. Lehrue Stevens Jr., MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 830 Bayou Pines Dr, The Pathology Laboratory, Lake Charles, LA 70601
Phone: 337-436-9557    Fax: 337-439-3085
Dr. Brandi J Kelly, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601
Phone: 337-436-9557    Fax: 337-312-1311
Dr. Regina Saretta Burton, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 830 W Bayou Pines Dr, Lake Charles, LA 70601
Phone: 337-436-9557    
Gault Henry Townsend, MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 830 Bayou Pines Dr, The Pathology Laboratory, Lake Charles, LA 70601
Phone: 337-436-9557    Fax: 337-439-3085
Carl Gregory Bowling, M.D.
Pathology
Medicare: Medicare Enrolled
Practice Location: 1701 Oak Park Blvd, Lake Charles, LA 70601
Phone: 337-494-3190    Fax: 337-494-2464

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.